Professional Overview

Luis Pena is a seasoned executive currently serving as the Founder, President, and CEO of Evommune, Inc., based in Palo Alto, CA. His expertise lies in the biotechnology and pharmaceutical industries, with a focus on product development, global portfolio planning, and leadership.

Experience Summary

Current Role

Luis Pena is the Founder, President, and CEO of Evommune, Inc., a position he has held since 2020. As the CEO, he oversees the overall strategy and direction of the company, driving innovation and growth in the biotechnology sector. Under his leadership, Evommune has been at the forefront of developing cutting-edge therapies.

Career Progression

Prior to founding Evommune, Luis held various senior roles at renowned companies, including Dermira Inc., where he served as the Founder & Chief Development Officer and Vice President of Product Development. He also worked at Stiefel, a GSK Company, as the Vice President, Head of Global Rx Development, and Senior Vice President of Global Portfolio Planning and Management. Earlier in his career, Luis was the Vice President of Product Development at Nuvelo and a Team Leader at Genentech.

Areas of Expertise

Luis Pena possesses a unique blend of industry-specific skills, technical competencies, and leadership capabilities. His areas of expertise include:

• Product development and lifecycle management

• Global portfolio planning and strategy

• Leadership and team management

• Biotechnology and pharmaceutical industry knowledge

Professional Impact

Throughout his career, Luis has been involved in numerous high-impact projects and initiatives, contributing significantly to the development and launch of various therapies. His leadership and vision have been instrumental in driving growth and innovation within the companies he has served.

Conclusion

Luis Pena's professional trajectory is marked by significant achievements, contributions, and a demonstrated ability to lead and grow companies in the biotechnology and pharmaceutical sectors. Currently, as the Founder, President, and CEO of Evommune, Inc., Luis continues to focus on driving innovation and growth, making him a valuable asset to the industry. His unique blend of expertise, leadership capabilities, and industry knowledge positions him as a key player in shaping the future of biotechnology and pharmaceuticals.